4th Induced Proximity-Based Drug Discovery Summit
Evvnt Promotion / evvnt
Archivio
23.07.2024 - 25.07.2024 The Hyatt Regency, 1 Ave de Lafayette, 02111 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
Temi della conferenza
Whilst PROTACs continue to make headwind, much of the heterobifunctional and monovalent opportunity beyond the ubiquitin proteosome system remains untapped, drawing in new and distinguished biopharma in the race to develop new stabilization, modulation, post-translational modification, and inactivation/activation modalities.
Whilst PROTACs continue to make headwind, much of the heterobifunctional and monovalent opportunity beyond the ubiquitin proteosome system remains untapped, drawing in new and distinguished biopharma in the race to develop new stabilization, modulation, post-translational modification, and inactivation/activation modalities.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2313820-3?pid=4832
Speakers: Andrew Zhang, Director, Chemical Biology, AstraZeneca, Brandon Turunen, Co-Founder and Chief Technology Officer, Solu Therapeutics and More.
URL:
Brochure: https://go.evvnt.com/2313820-3?pid=4832
Speakers: Andrew Zhang, Director, Chemical Biology, AstraZeneca, Brandon Turunen, Co-Founder and Chief Technology Officer, Solu Therapeutics and More.
Informazioni ed Iscrizioni:
https://go.evvnt.com/2313820-2?pid=4832
Ms. Isabella Hunter
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
